About NCCC
Donate Now
Press Center
Jobs
Newsletter SignUp
Get updates on the latest NCCC research findings and programs.
View Newsletters
Resources For:  

Sally Glaser

All Publications

Gomez SL, Lichtenstazjn D, Kurian AW, Telli ML, Chang ET, Keegan THM, Glaser SL, Clarke CA. Increasing mastectomy rates for early-stage breast cancer? Population-based trends from California (letter). J Clin Oncol. 2010; in press.

Gomez SL, Quach T, Horn-Ross P, Pham JT, Cockburn M, Chang ET, Keegan THM, Glaser SL, Clarke CA. Uncovering hidden disparities: disaggregating breast cancer incidence rates in Asian women by immigrant status. Amer J Pub Health. 2010; in press.

McClure LA, Glaser SL, Shema SJ, Allen L, Quesenberry C, John EM, Gomez SL. Availability and accuracy of medical record information on language usage by multi-ethnic cancer patients. J Immigrant Minority Health. 2009;Aug [epub].

Keegan THM, Clarke CA, Chang ET, Shema SJ, Glaser SL. Socioeconomic and racial/ethnic disparities in Hodgkin lymphoma survival: a population-based study. Cancer Causes Control. 2009;20:1881–1892.

Hausauer AK, Keegan THM, Chang ET, Glaser S, Howe H, Clarke CA. Recent breast cancer incidence changes by rural/urban and poverty status, United States, 1997-2004. BMC Medicine. 2009;7:31.

Carreon JD, Morton LM, Devesa SS, Clarke CA, Gomez SL, Glaser SL, Sakoda LC, Linet MS, Wang SS. Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996-2004. Cancer Causes Control 2008;19(10):1171-81.

Keegan TH, Le GM, McClure LA, Glaser SLAvailability and utility of body mass index for population-based cancer surveillance. Cancer Causes Control. 2008;19(1):51-7.

Keegan TH, Chang ET, John EM, Horn-Ross PL, Wrensch MR, Glaser SL, Clarke CA. Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004. Breast Cancer Res. 2007;9(5):R62.

Chang ET, Keegan THM, Gomez SL, Le GM, Clarke CA, So SK, Glaser SL. The burden of liver cancer in Asians and Pacific Islanders the Greater San Francisco Bay Area, 1990 through 2004. Cancer. 2007;109:2100-8. 

Keegan THM, Gomez SL, Clarke CA, Chan J, Glaser SLRecent trends in breast cancer incidence among 6 Asian groups in the Greater Bay Area of Northern California.  Int J Cancer. 2007;120:1324-9. 

Clarke CA, Glaser SL. Declines in breast cancer after the WHI: apparent impact of hormone therapy. CEBP. 2007;18:847-52.  

Glaser SL, Chang ET, Horning SJ, Clarke CA..  Understanding the validity of self-reported positive family history of lymphoma in extended families to facilitate genetic epidemiology and clinical practice.  Leuk Lymph. 2007;48:1110-18. 

Chang ET, Clarke CA, Glaser SL.  Making sense of seasonal fluctuations in lymphoma diagnosis (Invited Commentary).  Leuk Lymph. 2007;48:223-4. 

Clarke CA, Uratsu CS, Selby JV, Kushi LH, Glaser SL, Herrinton LJ. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence (letter).  J Clin Oncol. 2006;24:e49-50.  

Clarke CA, Purdie DM, Glaser SL.  Population attributable risk of breast cancer in white women associated with immediately modifiable risk factors. BMC Cancer. 2006;6:170. 

Gomez SL, Glaser SLMisclassification of race/ethnicity in a population-based cancer registry. Cancer Causes Control. 2006;17:771-781. 

Keegan THM, Glaser SL, Clarke CA, Dorfman RF, Mann RV, DiGiuseppe JA, Chang ET, Ambinder RF.  Body size, physical activity and risk of Hodgkin lymphoma in women.  Cancer Epidemiol Biomarkers Prev. 2006;15:1095-1101.  

Clarke CA, Undurraga DM, Harasty PJ, Glaser SL, Morton LM, Holly EA. Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer Epidemiol Biomarkers Prev. 2006;15:630-638. 

O'Malley C, Shema S, White E, Glaser S.  Incidence of male breast cancer in California, 1988-2000: Racial-ethnic variation in 1,759 men.  Breast Cancer Res Treatment. 2005;93:145-50.  
 
Keegan THM, Glaser SL, Clarke CA, Gulley ML, Craig FE, DiGiuseppe JA, Dorfman RF, Mann RB, Ambinder RF.  Epstein-Barr virus as a marker of survival after Hodgkin lymphoma: a population-based study.  J Clin Oncol. 2005;23:7604-13. 

Glaser SL, Clarke CA, Gomez SL, O'Malley CD, Purdie DM, West DW.  Cancer surveillance research: a vital subdiscipline of cancer epidemiology.  Cancer Causes Control. 2005;16:1009-19. 

Gomez SL, Glaser SL.  Quality of birthplace data from the cancer registry for Hispanics.  Cancer Causes Control. 2005;16:713-723. 

Clarke CA, Prehn AW, Keegan TH, Glaser SL, West DW. Response to letter by ward et al. Ann Epidemiol. 2005;15:426-7.

Clarke CA, Glaser SL, Keegan THM, Stroup A.  Neighborhood socioeconomic status and Hodgkin lymphoma incidence in California. Cancer Epidemiol Biomarkers Prev. 2005;14:1441-1447. 

Glaser SL, Keegan THM, Clarke CA, Trinh MA, Dorfman RF, Mann RB, DiGiuseppe JA, Ambinder RF.  Exposure to childhood infections and risk of EBV-defined Hodgkin's lymphoma in women.  Int J Cancer. 2005;115:599-605.  

Thorne L, Glaser SL, Gulley ML.  Real-Time PCR measures Epstein-Barr virus DNA in archival breast adenocarcinomas.  Diagn Molec Pathol. 2005;14:29-33. 

Gomez SL, Kelsey JL, Glaser SL, Lee MM, Sidney S.  Inconsistencies between self-reported ethnicity and ethnicity recorded in a health maintenance organization.  Ann Epidemiol. 2005;15:71-79. 

Le GM, O'Malley CD, Glaser SL, Lynch CF, Stanford JL, Keegan THM, West DW.  Breast implants following mastectomy: prevalence and impact on survival in a population-based cohort of women with early-stage breast cancer.  Breast Cancer Res. 2005;7:R184-R193. 

Ryan JL, Fan H, Glaser SL, Schichman SA, Raab-Traub N, Gulley ML. Epstein-Barr virus quantitation by real-time PCR: A novel approach to screen for the virus in paraffin-embedded tissues.  J Molec Diagn. 2004;6:378-85.  

Gomez SL, Kelsey JL, Glaser SL, Lee MM, Sidney S.  Immigration and acculturation in relation to health and health-related risk factors among specific Asian subgroups in a health maintenance organization.  Am J Public Health. 2004;94:1977-84. 

Glaser SL, Clarke CA, Keegan THM, Gomez SL, Nugent RA, Topol B, Stearns CB, Stewart SL.  Attenuation of social class and reproductive risk factors for Hodgkin lymphoma due to selection bias in controls.  Cancer Causes Control. 2004;15:731-9. 

Clarke CA, Glaser SLPopulation-based surveillance of HIV-associated cancers: utility of cancer registry data.  J Acquir Immune Defic Syndr. 2004;36:1083-91. 

Glaser SL, Hsu JL, Gulley ML.  Epstein-Barr virus and breast cancer: State of the evidence for viral carcinogenesis.  Cancer Epidemiol Biomarkers Prev. 2004;13:688-697. 

Glaser SL, Keegan THM, Clarke CA, Darrow L, Gomez SL, Dorfman RF, Mann RB, DiGiuseppe JA, Ambinder RF.  Smoking and Hodgkin's disease risk in women. Cancer Causes Control. 2004;15:387-397.  

Gomez SL, Glaser SL, Kelsey JL, Lee MM.  Bias in completeness of birthplace data for Asian groups in a population-based cancer registry. Cancer Causes Control. 2004;15:243-253. 

Gomez SL, Glaser SL.  Quality of birthplace information obtained from death certificates for Hispanics and Asians and Pacific Islanders.  Ethnicity Dis. 2004;14:292-295. 

Clarke CA, Glaser SL, Dorfman RF, Bracci PM, Eberle E, Holly EA. Expert review of non-Hodgkin lymphomas in a population-based cancer registry: reliability of diagnosis and subtype classifications. Cancer Epidemiol Biomarkers Prev. 2004;13:138-143. 

Glaser SL, Gulley ML, Borowitz M, Craig F, Mann RB, Stewart SL, Shema SJ, Ambinder RF.  Inter-and intra-observer reliability of Epstein-Barr virus detection in Hodgkin lymphoma using histochemical procedures.  Leuk Lymph. 2004;45:489-97.  

Le GM, Gomez SL, Clarke CA, Glaser SL, West DW.  Reply to correspondence re: Cancer incidence patterns among Vietnamese in the US and Ha Noi, Vietnam.  Int J Cancer. 2003;107:332. 

Glaser SL, Clarke CA, Nugent RA, Stearns CB, Dorfman RF.  Reproductive factors in Hodgkin's disease in women.  Am J Epidemiol. 2003;158:553-563. 

Glaser SL, Clarke CA, Gulley ML, Craig FE, DiGiuseppe JA, Dorfman RF, Mann RB, Ambinder RF. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-98. Cancer. 2003;98:300-309. 

Gomez SL, Le GM, Clarke CA, Glaser SL, France A, West D.  Cancer incidence patterns in Koreans in the US and in Kangwha, South Korea.  Cancer Causes Control. 2003;14:167-174. 

Gomez SL, Clarke CA, Glaser SL.  Cancer survival in US racial/ethnic groups: heterogeneity among Asian ethnic subgroups.  Arch Int Med (editor's correspondence). 2003;163:631-2. 

Glaser SL, Clarke CA, Darrow LA.  Hodgkin's disease etiology and novel viruses: clues from groups exposed to blood products (letter).  Int J Cancer. 2003;104:796-797. 

O'Malley C, Le G, Shema S, Glaser S, West D. Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: a population-based study. Cancer. 2003;97:1303-11.   

Glaser SL.  Correspondence re:  Yasui Y, et al. Breast cancer risk and "delayed" primary Epstein-Barr virus infection. Cancer Epidemiol Biomarkers Prev. 2001;10(1):9-16. Cancer Epidemiol Biomarkers Prev. 2003;12:73. 

Prehn AW, Topol B, Stewart S, Glaser SL, O'Connor L, West DW.  Differences in treatment patterns for localized breast cancer among Asian/Pacific Islander women. Cancer. 2002;95:2268-75. 

Prehn AW, Clarke C, Topol B, Glaser S, West D.  Increase in breast cancer incidence in middle-aged white women during the 1990s.  Ann Epidemiol. 2002;12:476-81. 

Le GM, Gomez SL, Clarke CA, Glaser SL, West DW.  Cancer incidence patterns among Vietnamese in the US and Ha Noi, Vietnam.  Int J Cancer. 2002;102:412-417. 

Clarke CA, Glaser SL, West DW, Ereman RR, Erdmann CA, Barlow JM, Wrensch MR.  Breast cancer incidence and mortality trends in an affluent population: Marin County, California, USA, 1990-1999.  Breast Cancer Res. 2002;4(6):R13. 

O'Malley CD, Prehn AW, Shema SJ, Glaser SL.  Racial/ethnic differences in survival rates in a population-based series of men with breast cancer. Cancer. 2002;94:2836-43. 

Glaser SL, Stearns CB.  Reliability of random-digit dialing screening calls to enumerate an adult female population. Am J Epidemiol. 2002;155:972-975. 

Lin S, Glaser S, Stewart S.  Reliability of self-reported reproductive factors and childhood social class indicators in a case-control study in women. Ann Epidemiol. 2002;12:242-7. 

Clarke CA, Glaser SL. Changing incidence of non-Hodgkin's lymphomas in the United States. Cancer. 2002;94:2015-23. 

Lin SS, Clarke CA, Prehn AW, Glaser SL, West DW.  Survival after prostate, breast, colorectal, and cervical cancer in Asian subpopulations in the US, 1988-94. Cancer. 2002;94:1175-1182. 

Gulley ML, Glaser SL, Craig FE, Borowitz MD, Mann RB, Shema SJ, Ambinder RF. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin's disease. Am J Clin Pathol. 2002;117:259-67. 

Glaser SL, Clarke CA, Nugent RA, Dorfman RF, Stearns CB.  Social class and risk of Hodgkin's disease in young adult women in 1988-94.  Int J Cancer. 2002;98:110-17. 

Glaser SL, Hsu JL.  Hodgkin's disease in Asians: Incidence patterns and risk factors in population-based data.  Leuk Res. 2002;26:261-269. 

Clarke CA, Glaser SL, Prehn AW.  Age-specific survival after Hodgkin's disease in a population-based cohort. Cancer Causes Control. 2001;12:803-812. 

Clarke CA, Glaser SL.  Epidemiologic trends in HIV-associated lymphomas. Crit Opin Clin Oncol. 2001;13:354-59. 

Glaser SL, Clarke CA, Stearns CB, Dorfman RF.  Age variation in Hodgkin's disease risk factors in older women: Evidence from a population-based case-control study. Leuk Lymph. 2001;42:997-1004. 

Glaser S, Dorfman R, Clarke C.  Expert review of the diagnosis and histologic classification of Hodgkin's disease in a population-based cancer registry: Interobserver reliability and impact on incidence and survival rates. Cancer. 2001;92:218-224. 

Clarke CA, Glaser SL, Dorfman RF, Mann R, DiGiuseppe JA, Prehn AW, Ambinder RF. Epstein-Barr virus and survival after Hodgkin's disease in a population-based series of women. Cancer. 2001;91:1579-87. 

Hsu J, Glaser S.  Epstein-Barr virus-associated malignancies: Epidemiologic patterns and etiologic implications. Crit Rev Oncol/Hematol. 2000;34:27-53. 

Clarke CA, Glaser SL.  Survival after acute myeloid leukemia (letter). New Engl J Med. 2000;342:358-9.  

Stewart SL, Swallen KC,  Glaser SL, Horn-Ross PL, West DW.  Comparison of methods to classify Hispanic ethnicity in a population-based cancer registry. Am J Epidemiol. 1999;149:1063-1071. 

Swallen KC, Glaser SL, Stewart SL, West DW, Jenkins C, McPhee S.  Accuracy of racial classification of Vietnamese patients in a population-based cancer registry. Ethnic Disease. 1998;8:218-227.  

Glaser SL, Ambinder RF, DiGiuseppe JA, Horn-Ross PL, Hsu JL.  Absence of Epstein-Barr virus in breast cancers from an epidemiologically diverse case series. Int J Cancer. 1998;75:555-558. 

Stewart SL, Swallen KC, Glaser SL, Horn-Ross PL, West DW.  Adjustment of cancer incidence rates for ethnic misclassification. Biometrics. 1998;54:774-781. 

Hsu JL, Glaser SL, West DW. Racial/ethnic differences in breast cancer survival among San Francisco Bay Area women. JNCI. 1997;89:1311-1312. 

Swallen KC, West DW, Stewart SL, Glaser SL, Horn-Ross PL. Predictors of misclassification of Hispanic ethnicity in a population-based cancer registry. Ann Epidemiol. 1997;7:200-206. 

Glaser SL, Lin RJ, Stewart SL, Ambinder RF, Jarrett RF, Brousset P, Pallesen G, Gulley M, Khan G, O'Grady J, Hummel M, Preciado MV, Knecht H, Chan JKC, Claviez A. Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data. Int J Cancer. 1997;70:375-382. 

Glaser SL, Jarrett RF. The epidemiology of Hodgkin's disease. Bailliere's Clin Haematol. 1996;9:401-416. 

Replogle M, Glaser S, Hiatt R, Parsonnet J.  Biologic sex as a risk factor for Helicobacter pylori infection in healthy young adults. Am J Epidemiol 1995;142:856-863. 

Glaser SReproductive factors in Hodgkin's disease in women: a review. Am J Epidemiol. 1994;139:237-246.  

Glaser SBlack white differences in Hodgkin's disease incidence in the U.S. by age, sex, histology subtype and time. Int J Epidemiol. 1991;20:68-75. 

Glaser S.  Hodgkin's disease in black populations: A review of the epidemiologic literature. Semin Oncol. 1990;17:643 659. 

Glaser S, Swartz W.  Time trends in Hodgkin's disease incidence. The role of diagnostic accuracy. Cancer. 1990;66:2196 2204.  

Glaser S.  Evidence for spatial clustering of Hodgkin's disease in the San Francisco Bay Area.  Am J Epidemiol. 1990;132:S167 S177. 

Glaser S.  Regional variation in Hodgkin's disease incidence by histologic subtype in the United States. Cancer. 1987;60:2841 2847. 

Glaser S.  Recent incidence and secular trends in Hodgkin's disease and its histologic subtypes. J Chronic Dis. 1986;39:789 798. 

Kaldor J, Harris JA, Glazer E, Glaser S, Neutra R, Mayberry R, Nelson V, Robinson L, Reed D. Statistical association between cancer incidence and major cause mortality, and estimated residential exposure to air emissions from petroleum and chemical plants. Environ Health Perspect. 1984;54:319 332. 

Reed D, Glaser S, Kaldor J. Ozone toxicity symptoms among flight attendants. Am J Indus Med. 1980;1:43-54. 


Back to Sally Glaser's profile

Back to Top
 

Fremont Bank Foundation

Northern California Cancer Center gratefully thanks and acknowledges the Fremont Bank Foundation for its sponsorship of our website.